You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港A異動丨流感概念股強勢 全國流感病毒陽性率持續上升
格隆匯 01-06 09:43

A股方面,魯抗醫藥2連板,眾生藥業升超8%,以嶺藥業、香雪製藥、海正藥業、普洛藥業等跟升;港股方面,東陽光長江藥業升超5%,山東新華製藥升超4%,和黃醫藥、凱萊英升超2%。消息面上,中國疾控中心最新數據,目前流感病毒陽性率持續上升,流感病毒陽性率“躍居第一”,其中99%以上為甲流。全國多地疾控緊急提醒。此外,北京市疾控中心對近期傳染病形勢做出説明,強調目前呼吸道傳染病感染呈現上升趨勢,其中,流感病毒感染預計在2025年1月上旬達到高峯。(格隆匯)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account